Ampreloxetine for Neurogenic Orthostatic Hypotension in MSA
Neurology Minute
Dr. Elizabeth Coon and Dr. Lucy Norcliffe-Kaufmann discuss the mechanism-based therapy with ampreloxetine for neurogenic orthostatic hypotension in multiple system atrophy, highlighting recent clinical trial results and future directions. Show citation: Freeman R, Kaufmann H, Biaggioni I, et al. Mechanism-Based Therapy With Ampreloxetine for Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Randomized Withdrawal Trial. Neurology. 2026;107(3):e218284. doi:
info_outline
Sex Differences in Levodopa Pharmacokinetics in Early Parkinson Disease
Neurology Minute
Dr. Margarita Fedorova explores sex-related differences in the pharmacokinetics of levodopa among levodopa-naïve patients with PD and evaluates their relationships with levodopa-related complications. Show citation: Conti V, De Bellis E, Corbi G, et al. Sex differences in levodopa pharmacokinetics in early Parkinson's disease: implications on levodopa-related complications. Front Pharmacol. 2026;17:1748932. Published 2026 Apr 7. doi:
info_outline
Psychiatric Comorbidities in Epilepsy - Part 2
Neurology Minute
In part two of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the steps to take if you are screening for a psychiatric comorbidity and the results indicate that someone may be positive for depression, anxiety, or another condition. Show citations: Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia. 2022;63(2):316-334. doi: Patel AD, Baca C, Franklin G, et al. Quality improvement in neurology: Epilepsy Quality Measurement Set 2017...
info_outline
August 2026 President Spotlight: How We’re Working with the AMA
Neurology Minute
In the August episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost highlight how the AAN’s growing representation within the AMA strengthens the voice of neurology. Stay informed by watching the .
info_outline
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 2
Neurology Minute
In part two of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the FENhance 1 and 2 trials looking at fenebrutinib in relapsing MS. For more information, please read about the abstract that was presented at the . Read more about the .
info_outline
Updates on BTK Inhibitors and Multiple Sclerosis Trials - Part 1
Neurology Minute
In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the . Read more about the .
info_outline
Psychiatric Comorbidities in Epilepsy - Part 1
Neurology Minute
In part one of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the best methods for screening patients with epilepsy in a clinical setting. Show citations: Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy. Epilepsia. 2022;63(2):316-334. doi: Patel AD, Baca C, Franklin G, et al. Quality improvement in neurology: Epilepsy Quality Measurement Set 2017 update. Neurology. 2018;91(18):829-836. doi:
info_outline
2026 International Conference on Functional Neurological Disorder - Part 2
Neurology Minute
In the second episode of this series, Dr. Dara Albert and Dr. Jon Stone discuss the future of FND and the innovative topics presented at the conference.
info_outline
Exploring Military Sexual Trauma and Migraine Among US Veterans - Part 2
Neurology Minute
In part two of this series, Dr. Stacey Clardy and Dr. John Ney discuss what neurologists should do differently after reading this article. Show citation: Ney J, Fenton B, Grinberg AS, et al. Association of Military Sexual Trauma With Migraine and Migraine-Related Health Care Utilization Among Post-9/11 US Veterans. Neurol Clin Pract. 2026;16(3):e200618. doi:
info_outline
2026 International Conference on Functional Neurological Disorder - Part 1
Neurology Minute
In the first episode of this series, Dr. Dara Albert and Dr. Jon Stone emphasize the main takeaway from this year's conference that should be taught to residents.
info_outlineIn the June episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss the sense of community present within the AAN.
Stay informed by watching the President's Spotlight video.
Show transcript:
Dr. Jason Crowell:
This is Jason Crowell with today's Neurology Minute. Once again, this month for our presidential spotlight, we have Natalia Rost joining us. Natalia, thanks so much for your time today.
Dr. Natalia Rost:
Hi, Jason.
Dr. Jason Crowell:
So what is on your mind this month, Natalia?
Dr. Natalia Rost:
Well, if you remember, last month we talked about our annual meeting, and since I've been thinking about AAN's value of community. Community is top of mind because staying connected, of course, sharing questions, experience, and ideas is how we keep improving care and advancing the field, but also how we elevate wellness for all of us.
Dr. Jason Crowell:
I'm sure there are many different ways we could talk about this sense of community showing up within the AAN, but what are you thinking of specifically?
Dr. Natalia Rost:
Well, of course, we love our annual meeting reunions, but one way we thrive as a community all year long is online through our AAN member sections. As you know, sections are our AAN vibrant member-led groups and each has a dedicated community on Synapse, our online community platform and mobile app. What you'll find there is discussions, resources, announcements, events, and peer Q&A.
Dr. Jason Crowell:
So can you give us some examples of how these sections work and how people participate?
Dr. Natalia Rost:
Yeah. Sections is our online community and our response onto how our field moves fast and sections are where you can stay connected and share knowledge. Every section is dedicated to a different subspecialty or interest. No matter where your focus is, there's probably an AAN online community. For instance, with my specialty in vascular neurology, I can connect with other members in the stroke and vascular neurology section. The topics can range from a tricky case question sharing a protocol or a career advice thread and we've done that for years now. But I'm also passionate about humanities and art, and so I can also explore the interface between neurology and the arts in my neuro-humanities synapse community. I highly recommend it.
Dr. Jason Crowell:
Are there any practical real-life benefits that members talk about when they're discussing these sections, and who all is behind the scenes making this work happen?
Dr. Natalia Rost:
Yeah. In addition to staying in touch all year long, many of our sections also host collaborative sessions during the annual meeting through section showcases. These are discussion-based sessions where sections present untimely topics. And if you're interested, I recommend joining a section now so you can stay on top of the advances for 2027. And for additional context, we also have 80-plus section leaders. These members offer their time and expertise to help their communities thrive, and so we're extremely grateful to them for their leadership.
Dr. Jason Crowell:
So if we have listeners today who are members of the AAN, but they've never gotten involved in these sections, where would you direct them? I imagine they can find information on the AAN website.
Dr. Natalia Rost:
Yes. So very simple. Any AAN member can join sections and access their communities on Synapse. Go to aan.com/sections and access them anywhere by downloading our Synapse mobile app. And my advice is very simple. Find your people, stay current, and bring your questions. Your section community is there year-round.
Dr. Jason Crowell:
Terrific. Natalia, thanks so much for sharing this with us.
Dr. Natalia Rost:
Thanks for having me.